Cardiology Continuing Medical Education
Be part of the knowledge.™Episodes 166-180 of 192
Sotatercept: A Novel Entity with Promising Potential for Treating PAH
MinuteCE®Sotatercept: A Novel Entity with Promising Potential for Treating PAH
Emerging Novel PH Therapies: Will They Impact Treatment Strategies?
MinuteCE®Emerging Novel PH Therapies: Will They Impact Treatment Strategies?
The Role of Inhaled Treprostinil For Treatment of PH-ILD
MinuteCE®The Role of Inhaled Treprostinil For Treatment of PH-ILD
PAH Clinical Consult: Getting to the Heart of PAH
CME/CEPAH Clinical Consult: Getting to the Heart of PAH
Understanding the 4-Strata Approach to Risk Assessment (RA) for Patient Monitoring and Management
MinuteCE®Understanding the 4-Strata Approach to Risk Assessment (RA) for Patient Monitoring and Management
Areas: A Look at the Importance of Physical Measurements of the Right Heart
MinuteCE®Areas: A Look at the Importance of Physical Measurements of the Right Heart
Genetic Testing in PAH: Cascade Genetic Testing Approach
MinuteCE®Genetic Testing in PAH: Cascade Genetic Testing Approach
Screening and Diagnosis of PAH: Cardiopulmonary Exercise Testing (CPET)
MinuteCE®Screening and Diagnosis of PAH: Cardiopulmonary Exercise Testing (CPET)
How Do We Screen For PAH in Systemic Sclerosis Patients?
MinuteCE®How Do We Screen For PAH in Systemic Sclerosis Patients?
Why Should We Screen for PAH in Systemic Sclerosis Patients?
MinuteCE®Why Should We Screen for PAH in Systemic Sclerosis Patients?
Will Lowering the Hemodynamic Threshold for PH Impact “Discovery” of New Patients?
MinuteCE®Will Lowering the Hemodynamic Threshold for PH Impact “Discovery” of New Patients?
Why Aren’t All Physicians Using Regular and Consistent Risk Assessment Protocols With Their PH Patients?
MinuteCE®Why Aren’t All Physicians Using Regular and Consistent Risk Assessment Protocols With Their PH Patients?
Case: A 54-Year-Old Woman With Progressive Dyspnea
MinuteCE®Case: A 54-Year-Old Woman With Progressive Dyspnea
